May 8 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS REPORTS FIRST QUARTER 2019
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q1 LOSS PER SHARE $0.55
* Q1 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES
DATA
* ALL CLINICAL PROGRAMS PROGRESSING ON TRACK;
* ALLENA PHARMACEUTICALS-SEES EXISTING CASH & CASH
EQUIVALENTS TO
BE SUFFICIENT TO FUND OPERATING EXPENSES & CAPITAL REQUIREMENTS
THROUGH AT LEAST 1H20
Source text for Eikon: ID:nGNX83yhRp
Further company coverage: ALNA.O
((Reuters.Briefs@thomsonreuters.com;))